D1 dopamine receptor-deficient mouse: Cocaine-induced regulation of immediate-early gene and substance P expression in the striatum

Neuroscience

Volumn 74, Issue 3, 1996, Pages 813-823

  Drago, J ^a,c   Gerfen, C R ^b   Westphal, H ^a   Steiner, H ^b,d  

^a EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH AND HUMAN DEVELOPMENT   (United States)

^b NATIONAL INSTITUTE OF MENTAL HEALTH   (United States)

^c MONASH UNIVERSITY   (Australia)

^d UNIVERSITY OF TENNESSEE COLLEGE OF MEDICINE   (United States)

Author keywords

Amphetamine; c fos; Dynorphin; Enkephalin; Neuropeptide; zif268

Indexed keywords

COCAINE; DOPAMINE 1 RECEPTOR; SUBSTANCE P;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CORPUS STRIATUM; HISTOCHEMISTRY; IMMEDIATE EARLY GENE; IN SITU HYBRIDIZATION; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL;

EID: 0030564958     PISSN: 03064522     EISSN: None     Source Type: Journal    
DOI: 10.1016/0306-4522(96)00145-5     Document Type: Article

References (63)

1. Accili D., Fishburn C.S., Drago J., Steiner H., Lachowicz J.E., Park B.-H., Gauda E.B., Lee E.J., Cool M.H., Sibley D.R., Gerfen C.R., Westphal H., Fuchs S. A targeted mutation of the D3 dopamine receptor gene is associated with hyperactivity in mice. Proc. natn. Acad. Sci. U.S.A. 93:1996;1945-1949.
2. Baik J.-H., Picetti R., Saiardi A., Thiriet G., Dierich A., Depaulis A., Le Meur M., Borrelli E. Parkinsonian-like locomotor impairment in mice lacking dopamine D2 receptors. Nature, Lond. 377:1995;424-428.
3. Bannon M.J., Elliott P.J., Bunney E.B. Striatal tachykinin biosynthesis: regulation of mRNA and peptide levels by dopamine agonists and antagonists. Molec. Brain Res. 3:1987;31-37.
4. Beckstead R.M., Kersey K.S. Immunohistochemical demonstration of differential substance P-, Met-enkephalin-, and glutamic acid decarboxylase-containing cell and axon distributions in the corpus striatum of the cat. J. comp. Neurol. 232:1985;481-498.
5. Berretta S., Robertson H.A., Graybiel A.M. Dopamine and glutamate agonists stimulate neuron-specific expression of Fos-like protein in the striatum. J. Neurophysiol. 68:1992;767-777.
6. Bhat R.V., Baraban J.M. Activation of transcription factor genes in striatum by cocaine: role of both serotonin and dopamine systems. J. Pharmac. exp. Ther. 267:1993;496-505.
7. Bradberry C.W., Nobiletti J.B., Elsworth J.D., Murphy B., Jatlow P., Roth R.H. Cocaine and cocaethylene: microdialysis comparison of brain drug levels and effects on dopamine and serotonin. J. Neurochem. 60:1993;1429-1435.
8. Breese G.R., Duncan G.E., Napier T.C., Bondy S.C., Iorio L.C., Mueller R.A. 6-Hydroxydopamine treatments enhance behavioral responses to intracerebral microinjection of D1- and D2-dopamine agonists into nucleus accumbens and striatum without changing dopamine antagonist binding. J. Pharmac. exp. Ther. 240:1987;167-176.
9. Briggs C.A., Pollock N.J., Frail D.E., Paxson C.L., Rakowski R.F., Kang C.H., Kebabian J.W. Activation of 5-HTIC receptor expressed in Xenopus oocytes by the benzazepines SCH 23390 and SKF 38393. Br. J. Pharmac. 104:1991;1038-1044.
10. Cabib S., Castellano C., Cestari V., Filibeck U., Puglisi-Allegra S. D1 and D2 receptor antagonists differently affect cocaine-induced locomotor hyperactivity in the mouse. Psychopharmacology. 105:1991;335-339.
11. Cenci M.A., Björklund A. Transection of corticostriatal afferents reduces amphetamine- and apomorphine-induced striatal Fos expression and turning behaviour in unilaterally 6-hydroxydopamine-lesioned rats. Eur. J. Neurosci. 5:1993;1062-1070.
12. Cenci M.A., Campbell K., Björklund A. Neuropeptide messenger RNA expression in the 6-hydroxydopamine-lesioned rat striatum reinnervated by fetal dopaminergic transplants: differential effects of the grafts on preproenkephalin, preprotachykinin and prodynorphin messenger RNA levels. Neuroscience. 57:1993;275-296.
13. Cenci M.A., Campbell K., Wictorin K., Björklund A. Striatal c-fos induction by cocaine or apomorphine occurs preferentially in output neurons projecting to the substantia nigra in the rat. Eur. J. Neurosci. 4:1992;376-380.
14. Chandler C.J., Wohab W., Starr B.S., Starr M.S. Motor depression: a new role for D1 receptors? Neuroscience. 38:1990;437-445.
15. 1 dopamine receptor activation of multiple transcription factor genes in rat striatum. J. Neurochem. 58:1992;1420-1426.
16. Daunais J.B., McGinty J.F. Acute and chronic cocaine administration differentially alters striatal opioid and nuclear transcription factor mRNAs. Synapse. 18:1994;35-45.
17. Di Chiara G., Imperato A. Drugs abused by humans preferentially increase synaptic dopamine concentrations in the mesolimbic system of freely moving rats. Proc. natn. Acad. Sci. U.S.A. 85:1988;5274-5278.
18. Drago J., Gerfen C.R., Lachowicz J.E., Steiner H., Hollon T.R., Love P.E., Ooi G.T., Grinberg A., Lee E.J., Huang S.P., Bartlett P.F., Jose P.A., Sibley D.R., Westphal H. Altered striatal function in a mutant mouse lacking D1A dopamine receptors. Proc. natn. Acad. Sci. U.S.A. 91:1994;12564-12568.
19. 2 receptor stimulation on somatostatin, neuropeptide Y, neurotensin, dynorphin and enkephalin. Brain Res. 581:1992;261-268.
20. Fitzgerald L.W., Deutch A.Y., Gasic G., Heinemann S.F., Nestler E.J. Regulation of cortical and subcortical glutamate receptor subunit expression by antipsychotic drugs. J. Neurosci. 15:1995;2453-2461.
21. 1 dopamine receptor mRNA in brain supports a role in cognitive, affective, and neuroendocrine aspects of dopaminergic neurotransmission. Proc. natn. Acad. Sci. U.S.A. 88:1991;3772-3776.
22. 2 dopamine receptor-regulated gene expression of striatonigral and striatopallidal neurons. Science. 250:1990;1429-1432.
23. Gerfen C.R., McGinty J.F., Young W.S. III Dopamine differentially regulates dynorphin, substance P, and enkephalin expression in striatal neurons: in situ hybridization histochemical analysis. J. Neurosci. 11:1991;1016-1031.
24. Gerfen C.R., Young W.S. III Distribution of striatonigral and striatopallidal peptidergic neurons in both patch and matrix compartments: an in situ hybridization histochemistry and fluorescent retrograde tracing study. Brain Res. 460:1988;161-167.
25. Graybiel A.M., Moratalla R., Robertson H.A. Amphetamine and cocaine induce drug-specific activation of the c-fos gene in striosome-matrix compartments and limbic subdivisions of the striatum. Proc. natn. Acad. Sci. U.S.A. 87:1990;6912-6916.
26. Hanson G.R., Merchant K.M., Letter A.A., Bush L., Gibb J.W. Characterization of methamphetamine effects on the striatal-nigral dynorphin system. Eur. J. Pharmac. 155:1988;11-18.
27. 3H]SCH 23390-labeled D1 dopamine receptors in rat striatum. Eur. J. Pharmac. 121:1986;31-38.
28. Hoffman D.C., Beninger R.J. The D1 dopamine receptor antagonist, SCH 23390 reduces locomotor activity and rearing in rats. Pharmac. Biochem. Behav. 22:1985;341-342.
29. Hope B., Kosofsky B., Hyman S.E., Nestler E.J. Regulation of immediate early gene expression and AP-1 binding in the rat nucleus accumbens by chronic cocaine. Proc. natn. Acad. Sci. U.S.A. 89:1992;5764-5768.
30. Hurd Y.L., Brown E.E., Finlay J.M., Fibiger H.C., Gerfen C.R. Cocaine self-administration differentially alters mRNA expression of striatal peptides. Molec. Brain Res. 13:1992;165-170.
31. Hurd Y.L., Herkenham M. Influence of a single injection of cocaine, amphetamine or GBR 12909 on mRNA expression of striatal neuropeptides. Molec. Brain Res. 16:1992;97-104.
32. Johansson B., Lindström K., Fredholm B.B. Differences in the regional and cellular localization of c-fos messenger RNA induced by amphetamine, cocaine and caffeine in the rat. Neuroscience. 59:1994;837-849.
33. Keefe K.A., Gerfen C.R. D1-D2 dopamine receptor synergy in striatum: effects of intrastriatal infusions of dopamine agonists and antagonists on immediate early gene expression. Neuroscience. 66:1995;903-913.
34. Kiyatkin E.A. Enhanced locomotor reactivity to apomorphine following repeated cocaine treatment. Pharmac. Biochem. Behav. 49:1994;247-251.
35. Kosofsky B.E., Genova L.M., Hyman S.E. Substance P phenotype defines specificity of c-fos induction by cocaine in developing rat striatum. J. comp. Neurol. 351:1995;41-50.
36. Kuczenski R., Segal D.S. Differential effects of amphetamine and dopamine uptake blockers (cocaine, nomifensine) on caudate and accumbens dialysate dopamine and 3-methoxytyramine. J. Pharmac. exp. Ther. 262:1992;1085-1094.
37. Kuczenski R., Segal D.S., Cho A.K., Melega W. Hippocampus norepinephrine, caudate dopamine and serotonin, and behavioral responses to the stereoisomers of amphetamine and methamphetamine. J. Neurosci. 15:1995;1308-1317.
38. Le Moine C., Normand E., Bloch B. Phenotypical characterization of the rat striatal neurons expressing the D1 dopamine receptor gene. Proc. natn. Acad. Sci. U.S.A. 88:1991;4205-4209.
39. Li S.J., Sivam S.P., McGinty J.F., Huang Y.S., Hong J.S. Dopaminergic regulation of tachykinin metabolism in the striatonigral pathway. J. Pharmac. exp. Ther. 243:1987;792-798.
40. Li S.J., Sivam S.P., McGinty J.F., Jiang H.K., Douglass J., Calavetta L., Hong J.S. Regulation of the metabolism of striatal dynorphin by the dopaminergic system. J. Pharmac. exp. Ther. 246:1988;403-408.
41. Mansour A., Meador-Woodruff J.H., Zhou Q.-Y., Civelli O., Akil H., Watson S.J. A comparison of D1 receptor binding and mRNA in rat brain using receptor autoradiographic and in situ hybridization techniques. Neuroscience. 45:1991;359-371.
42. 1 receptor mRNA in human and rat brain. Molec. Brain Res. 10:1991;185-191.
43. Meyer M.E., Cottrell G.A., Van Hartesveldt C., Potter T.J. Effects of dopamine D1 antagonists SCH-23390 and SKF-83566 on locomotor activities in rats. Pharmac. Biochem. Behav. 44:1993;429-432.
44. Moratalla R., Robertson H.A., Graybiel A.M. Dynamic regulation of NGFI-A (zif268, egr1) gene expression in the striatum. J. Neurosci. 12:1992;2609-2622.
45. Nestler E.J. Molecular mechanisms of drug addiction. J. Neurosci. 12:1992;2439-2450.
46. 1c receptors in the choroid plexus. J. Pharmac. exp. Ther. 247:1988;343-348.
47. Nisenbaum L.K., Kitai S.T., Crowley W.R., Gerfen C.R. Temporal dissociation between changes in striatal enkephalin and substance P messenger RNAs following striatal dopamine depletion. Neuroscience. 60:1994;927-937.
48. Paxinos G. and Watson C. (1982) The Rat Brain in Stereotaxic Coordinates. Academic Press, New York.
49. 2 receptors in adult rat brain after neonatal destruction of nigrostriatal dopamine neurons: a quantitative autoradiographic study. Brain Res. 606:1993;273-285.
50. Reith M.E. 5-HT3 receptor antagonists attenuate cocaine-induced locomotion in mice. Eur. J. Pharmac. 186:1990;327-330.
51. 1 dopamine receptor-activated c-fos. Brain Res. 523:1990;288-290.
52. 2 dopamine receptors differentially regulate c-fos expression in striatonigral and striatopallidal neurons. Neuroscience. 49:1992;285-296.
53. Sibley D.R., Monsma F.J. Jr. Molecular biology of dopamine receptors. Trends pharmac. Sci. 13:1992;61-69.
54. Sivam S.P. Cocaine selectively increases striatonigral dynorphin levels by a dopaminergic mechanism. J. Pharmac. exp. Ther. 250:1989;818-824.
55. Steiner H., Gerfen C.R. Cocaine-induced c-fos messenger RNA is inversely related to dynorphin expression in striatum. J. Neurosci. 13:1993;5066-5081.
56. 1 dopamine receptor-mediated immediate-early gene expression in the striatum. J. comp. Neurol. 353:1995;200-212.
57. Tella S.R. Differential blockade of chronic versus acute effects of intravenous cocaine by dopamine receptor antagonists. Pharmac. Biochem. Behav. 48:1994;151-159.
58. Vincent S.R., Hökfelt T., Christensson I., Terenius L. Immunohistochemical evidence for a dynorphin immunoreactive striatonigral pathway. Eur. J. Pharmac. 85:1982;251-252.
59. Voorn P., Roest G., Groenewegen H.J. Increase of enkephalin and decrease of substance P immunoreactivity in the dorsal and ventral striatum of the rat after midbrain 6-hydroxydopamine lesions. Brain Res. 412:1987;391-396.
60. 1 receptor mutant mice. Cell. 79:1994;945-955.
61. Xu M., Moratalla R., Gold L.H., Hiroi N., Koob G.F., Graybiel A.M., Tonegawa S. Dopamine D1 receptor mutant mice are deficient in striatal expression of dynorphin and in dopamine-mediated behavioral responses. Cell. 79:1994;729-742.
62. 1 receptors. Proc. natn. Acad. Sci. U.S.A. 88:1991;1291-1295.
63. Young W.S. III, Bonner T.I., Brann M.R. Mesencephalic dopamine neurons regulate the expression of neuropeptide mRNAs in the rat forebrain. Proc. natn. Acad. Sci. U.S.A. 83:1986;9827-9831.